• Mashup Score: 3
    Project Confirm - 1 year(s) ago

    Promoting the transparency of Accelerated Approval for oncology indications

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      What is accelerated approval? Learn about accelerated approval for oncology drugs at the FDA's Oncology Center of Excellence. Watch a short video below and visit #OCEProjectConfirm to learn more: https://t.co/eHHhpywEcK #AcceleratedApproval #OCEProjectCommunity https://t.co/SH6MLUU1gC

  • Mashup Score: 2
    Project Confirm - 2 year(s) ago

    Promoting the transparency of Accelerated Approval for oncology indications

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      FDA's Accelerated Approval is 30 years old this year. The first #AcceleratedApproval in oncology was granted on October 4, 1995, to bicalutamide in combination with an LHRH analogue for advanced #prostatecancer. Learn more with #OCEProjectConfirm 👇 https://t.co/SByEFforxu https://t.co/QWiiUMsKkY

  • Mashup Score: 0
    Project Confirm - 2 year(s) ago

    Promoting the transparency of Accelerated Approval for oncology indications

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      FDA's Accelerated Approval is 30 years old this year. The first #AcceleratedApproval in oncology was granted on October 4, 1995, to bicalutamide in combination with an LHRH analogue for advanced #prostatecancer. Learn more with #OCEProjectConfirm 👇 https://t.co/SByEFforxu https://t.co/YiOj78c0yK

  • Mashup Score: 1
    Gautam Mehta on Precision Oncology An Overview of the Accelerated Approval Program - The ASCO Post - 2 year(s) ago

    AACR Annual Meeting 2022 Gautam Mehta, MD, of the U.S. Food and Drug Administration, discusses how accelerated approval of potentially life-saving cancer therapies has been applied in precision oncology. Although “fast-tracking” drugs presents opportunities and challenges, one possible measure of the program’s success is the fact that, to date, no…

    Source: ascopost.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      OCE's Gautam Mehta, MD, discusses how accelerated approval of potentially life-saving cancer therapies has been applied in precision oncology - via @ASCOPost #AACR22 #acceleratedapproval #OCEProjectConfirm https://t.co/u50DaJn7ST

  • Mashup Score: 2
    Program Planner - 2 year(s) ago

    Program Planner One fine bodyďż˝

    Source: www.abstractsonline.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      Accelerated, conditional, provisional or temporary approval? Mon 4/11 @ #AACR22, join #FDAOncology's #ProjectOrbis & #OCEProjectConfirm and international regulators to compare expedited approval programs, 12:30 pm CT. https://t.co/dQxKtGxIY5 https://t.co/TrI307ig3s

  • Mashup Score: 0
    Project Confirm - 2 year(s) ago

    Promoting the transparency of Accelerated Approval for oncology indications

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      FDA's Accelerated Approval is 30 years old this year. The first #AcceleratedApproval in oncology was granted on October 4, 1995, to bicalutamide in combination with an LHRH analogue for advanced #prostatecancer. Learn more with #OCEProjectConfirm 👇 https://t.co/SByEFforxu https://t.co/4IQf3KnEPJ

  • Mashup Score: 0
    Project Confirm - 2 year(s) ago

    Promoting the transparency of Accelerated Approval for oncology indications

    Source: U.S. Food and Drug Administration
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of FDAOncology
      FDAOncology

      To date, most Accelerated Approvals have been granted for oncology indications, but did you know that #AcceleratedApproval was first developed in 1992 in response to the HIV/AIDS crisis? Learn more with #OCEProjectConfirm 👇 https://t.co/SByEFforxu https://t.co/bTZwJrReaQ

Load More